Aligos Therapeutics, Inc. (ALGS) Shareholders’ equity 2020–2025
Aligos Therapeutics, Inc. (ALGS) shareholders’ equity at each fiscal year-end, per SEC filings.
$53.5MFY2025 · since FY2020: $220.0M → $53.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $53.5M | +284.8% |
| FY2024 | -$29.0M | -131.5% |
| FY2023 | $92.1M | -11.4% |
| FY2022 | $103.9M | -43.8% |
| FY2021 | $184.7M | -16.0% |
| FY2020 | $220.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice